Eargo Stock Price, News & Analysis (NASDAQ:EAR) $2.59 -0.01 (-0.38%) (As of 11/29/2023 ET) Add Compare Share Share Today's Range$2.57▼$2.6250-Day Range$1.60▼$2.6152-Week Range$1.47▼$16.80Volume26,736 shsAverage Volume72,494 shsMarket Capitalization$53.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media About Eargo Stock (NASDAQ:EAR)Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.Read More EAR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EAR Stock News HeadlinesNovember 23, 2023 | bizjournals.comOnce hot to go public, life sciences companies like Eargo now look at going privateNovember 16, 2023 | msn.comEargo Black Friday & Cyber Monday DealsNovember 30, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 16, 2023 | msn.comGet this 6-in-1 charging cable for just $17 ahead of Black FridayNovember 16, 2023 | msn.comEargo Hearing Aid Cost and PricingNovember 15, 2023 | msn.comEargo 6 ReviewNovember 8, 2023 | morningstar.comEargo Inc Ordinary Shares EARNovember 1, 2023 | benzinga.comMoore Kuehn Encourages CSTR, DOC, EAR, and SRC Investors to Contact Law FirmNovember 30, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 1, 2023 | finance.yahoo.comEargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and InnovationNovember 1, 2023 | msn.comBest Over-the-Counter Hearing Aid for YouOctober 30, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EAR, SUM, PXDOctober 30, 2023 | tmcnet.comEAR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Eargo, Inc. Is Fair to ShareholdersOctober 30, 2023 | benzinga.comEargo Shares Are Soaring Monday: What's Driving The Action?October 30, 2023 | msn.comEargo stock +50% after hearing aids maker to be taken private for $2.55/shareOctober 30, 2023 | investorplace.comWhy Is Eargo (EAR) Stock Up 50% Today?October 30, 2023 | marketwatch.comEargo to Be Taken Private by Patient Square CapitalOctober 30, 2023 | marketwatch.comEargo Shares Surge Toward Take-Private Deal PriceOctober 27, 2023 | finanznachrichten.deEargo Inc: Eargo Expands Relationship with Best Buy, Growing In-Store Presence to Over 500 LocationsOctober 26, 2023 | marketwatch.comEargo Shares Pop 16% on Deal to Sell Hearing Aids at Best BuyOctober 26, 2023 | finance.yahoo.comEargo Expands Relationship with Best Buy, Growing In-Store Presence to Over 500 LocationsOctober 11, 2023 | msn.comShop our Accessibility editor's top Prime Day deals for adaptive livingOctober 10, 2023 | msn.comThe best October Prime Day OTC Hearing Aid deals happening nowOctober 4, 2023 | businesswire.comUS Hearing Aid Market Sees Rapid Growth Fueled by Technological Advancements and Regulatory Changes - ResearchAndMarkets.comOctober 2, 2023 | uk.finance.yahoo.comRevolutionizing Access: OTC Hearing Aid Act Transforms the United States Hearing Aid Market to 2028September 28, 2023 | tmcnet.comUS Hearing Aid Market Valued at $2.71 Billion in 2022, Expected to Reach $3.98 Billion by 2028 with Technological AdvancementsAugust 16, 2023 | forbes.comEargo Hearing Aids Review: Models, Costs, Pros And ConsSee More Headlines Receive EAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eargo and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/07/2023Today11/30/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:EAR CUSIPN/A CIK1719395 Webeargo.com Phone650-351-7700FaxN/AEmployees243Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($7.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-157,490,000.00 Net Margins-263.14% Pretax Margin-262.90% Return on Equity-135.08% Return on Assets-96.37% Debt Debt-to-Equity RatioN/A Current Ratio3.22 Quick Ratio2.97 Sales & Book Value Annual Sales$41.11 million Price / Sales1.31 Cash FlowN/A Price / Cash FlowN/A Book Value$2.17 per share Price / Book1.19Miscellaneous Outstanding Shares20,762,000Free Float20,594,000Market Cap$53.77 million OptionableNot Optionable Beta1.53 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. William H. Brownie (Age 56)Interim CEO & COO Comp: $625.2kMr. Adam Laponis (Age 47)Chief Financial Officer Comp: $586.2kMr. Daniel ShenCo-Founder and Chief Clinical & Science OfficerMr. Mark Thorpe (Age 55)Chief Accounting Officer Mr. Tim Trine Ph.D.Chief Technology OfficerMs. Christy La PierreChief Legal Officer & SecretaryMs. Tricia BurchellSenior Vice President of People OperationsMore ExecutivesKey CompetitorsMilestone ScientificNYSE:MLSSCollPlant BiotechnologiesNASDAQ:CLGNReWalk RoboticsNASDAQ:RWLKOceanTech Acquisitions INASDAQ:OTECVicarious SurgicalNYSE:RBOTView All CompetitorsInsidersWilliam BrownieSold 1,514 sharesTotal: $4,844.80 ($3.20/share)Adam LaponisSold 19 sharesTotal: $61.56 ($3.24/share)Mark ThorpeSold 3 sharesTotal: $9.69 ($3.23/share)Christian GormsenSold 58 sharesTotal: $272.02 ($4.69/share)Adam LaponisSold 19 sharesTotal: $89.11 ($4.69/share)View All Insider Transactions EAR Stock Analysis - Frequently Asked Questions How have EAR shares performed in 2023? Eargo's stock was trading at $11.50 at the start of the year. Since then, EAR stock has decreased by 77.5% and is now trading at $2.59. View the best growth stocks for 2023 here. Are investors shorting Eargo? Eargo saw a drop in short interest in November. As of November 15th, there was short interest totaling 127,200 shares, a drop of 60.3% from the October 31st total of 320,200 shares. Based on an average trading volume of 103,800 shares, the short-interest ratio is presently 1.2 days. Currently, 3.7% of the company's stock are short sold. View Eargo's Short Interest. When is Eargo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024. View our EAR earnings forecast. How were Eargo's earnings last quarter? Eargo, Inc. (NASDAQ:EAR) announced its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.71) EPS for the quarter. The business had revenue of $8.27 million for the quarter. Eargo had a negative net margin of 263.14% and a negative trailing twelve-month return on equity of 135.08%. When did Eargo's stock split? Eargo shares reverse split before market open on Wednesday, January 18th 2023. The 1-20 reverse split was announced on Wednesday, January 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Eargo IPO? (EAR) raised $100 million in an initial public offering on Friday, October 16th 2020. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. J.P.Morgan and BofA Securities acted as the underwriters for the IPO and Wells Fargo Securities and William Blair were co-managers. Who are Eargo's major shareholders? Eargo's stock is owned by a variety of institutional and retail investors. Top institutional investors include Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Adam Laponis, Christian Gormsen, David James Wu, Geoff Pardo, Healthcare Holding BV Gilde, Mark Thorpe, Mohamad Makhzoumi, Nina Richardson and William Brownie. View institutional ownership trends. How do I buy shares of Eargo? Shares of EAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:EAR) was last updated on 11/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.